Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175576 · ClinicalTrials.gov registry record · NA
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02175576: Clinical Trial NA study, sponsored by Zimmer Biomet.
NCT02175576 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02175576, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.
Primary Outcome
Participants answered a Single Assessment Numeric Evaluation (SANE) which asked how they rated their knee function. A score of 100 indicates normal and anything below 100 indicates a percentage of normal function.
Interventions
- DEVICE Vanguard XP Bicruciate Knee System
- DEVICE Vanguard CR Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-12 |
| Phase | NA |
Why NCT02175576 stopped before completion
NCT02175576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Vanguard XP Bicruciate Knee System is the first listed.
NCT02175576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02175576 about?
NCT02175576 is a clinical study titled "Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System". Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.
What is the current status of trial NCT02175576?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2014-10. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02175576?
The interventions under investigation include: Vanguard XP Bicruciate Knee System (DEVICE), Vanguard CR Knee System (DEVICE).
Who is sponsoring clinical trial NCT02175576?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02175576's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia